As of 2025-11-04, the Relative Valuation of Insmed Inc (INSM) is (78.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 186.23 USD, the upside of Insmed Inc based on Relative Valuation is -142.2%.
The range of the Relative Valuation is (76.53) - (96.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 22.7x | 17.0x |
| Forward P/E multiples | 13.4x - 19.8x | 15.1x |
| Fair Price | (76.53) - (96.99) | (78.54) |
| Upside | -141.1% - -152.1% | -142.2% |
| Date | P/E |
| 2025-10-31 | -38.75 |
| 2025-10-30 | -39.69 |
| 2025-10-29 | -34.12 |
| 2025-10-28 | -33.78 |
| 2025-10-27 | -33.52 |
| 2025-10-24 | -32.63 |
| 2025-10-23 | -32.72 |
| 2025-10-22 | -32.78 |
| 2025-10-21 | -33.78 |
| 2025-10-20 | -34.31 |
| 2025-10-17 | -33.87 |
| 2025-10-16 | -33.35 |
| 2025-10-15 | -33.42 |
| 2025-10-14 | -32.98 |
| 2025-10-13 | -33.50 |
| 2025-10-10 | -33.17 |
| 2025-10-09 | -33.60 |
| 2025-10-08 | -33.07 |
| 2025-10-07 | -33.17 |
| 2025-10-06 | -32.34 |
| 2025-10-03 | -32.12 |
| 2025-10-02 | -31.23 |
| 2025-10-01 | -30.10 |
| 2025-09-30 | -29.43 |
| 2025-09-29 | -28.95 |
| 2025-09-26 | -28.00 |
| 2025-09-25 | -27.71 |
| 2025-09-24 | -28.81 |
| 2025-09-23 | -29.71 |
| 2025-09-22 | -29.64 |
| 2025-09-19 | -29.58 |
| 2025-09-18 | -29.81 |
| 2025-09-17 | -29.59 |
| 2025-09-16 | -29.58 |
| 2025-09-15 | -29.25 |
| 2025-09-12 | -29.82 |
| 2025-09-11 | -29.79 |
| 2025-09-10 | -29.82 |
| 2025-09-09 | -30.08 |
| 2025-09-08 | -29.97 |
| 2025-09-05 | -29.65 |
| 2025-09-04 | -29.13 |
| 2025-09-03 | -29.32 |
| 2025-09-02 | -29.69 |
| 2025-08-29 | -27.81 |
| 2025-08-28 | -27.58 |
| 2025-08-27 | -27.49 |
| 2025-08-26 | -27.01 |
| 2025-08-25 | -26.22 |
| 2025-08-22 | -26.95 |